Request Sample Inquiry
Gene Synthesis Market

Gene Synthesis Market

Gene Synthesis Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:


Base Year:



Feb - 2022



Report Code:


Segments Covered
  • By End User By End User Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations
  • By Method By Method Oligonucleotide Synthesis, Gene Assembly
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 1.75 Billion
Revenue 2030Revenue 2030: USD 8.58 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 17.60%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Gene Synthesis Market Share

Market Synopsis:

Global Gene Synthesis Market is valued at USD 1.75 Billion in 2022 and is projected to attain a value of USD 8.58 Billion by 2030 at a CAGR of 17.60% during the forecast period, 2022–2028. Gene Synthesis is the chemical synthesis of double-stranded DNA molecules in a laboratory setting. It is a biotechnology technique that is crucial in the realm of synthetic biology. Various sectors of recombinant DNA technology, such as gene therapy, vaccine development, molecular engineering, and heterologous gene expression, have benefited from the technology. It could aid in the development of new enzymes for cancer treatment. It can also be used to diagnose viral genomes in real time for vaccine development. Without using a template DNA strand, Gene Synthesis can create mutant, recombinant, or wholly new DNA sequences. It can also make oligos and RNA with changed bases or chimeric DNA-RNA backbones, in addition to DNA sequences.

Gene Synthesis Market Size, 2022 To 2030 (USD Billion)

AI (GPT) is here !!! Ask questions about Gene Synthesis Market

In the most hopeful scenario, the COVID-19 pandemic would have a long-term positive impact on the global Gene Synthesis business. In early 2020, the COVID-19 pandemic had a detrimental impact on the Gene Synthesis market, as most dental offices, clinics, and laboratories were forced to close due to lockdowns and quarantine regulations in many regions of the world. However, most regions, particularly North America and Europe, are recovering as laboratory services has return to normalcy.

Supportive Government Policies

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

The market is fueled by government regulations that favour synthetic biology. Investors have moved their focus to synthetic biology in recent years as demand for the technology has grown. By 2020, the synthetic biology field will have received around USD 8 billion in governmental and private funding. In terms of fresh growth potential, the ongoing COVID-19 epidemic has been beneficial to the market. Scientific communities are researching uncharted territory in the space, resulting in increased revenue. Researchers at the National Institute of Standards and Technology (NIST), for example, have created synthetic COVID-19 viral gene segments to aid diagnostic developers in developing more reliable and accurate diagnostic tests for the disease.

Long Approval Time

Long approval times for gene synthesisers and the goods synthesised with these products limit product producers' ability to gain a competitive advantage in the market, reducing total market size and so posing a hurdle to the gene synthesis market's growth.

Market Segmentation:

The Global Gene Synthesis Market can be segmented by End User into Academic and Research Institutes, Biopharmaceutical Companies and Contract Research Organizations. By Method into Oligonucleotide Synthesis and Gene Assembly. Based on Region, the Gene Synthesis Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Below tree is interactive. You can click the nodes to get more information.

North America to Continue Dominating the Gene Synthesis Market

Owing to the existence of key companies and supported government activities relevant to the training and execution of synthetic biology programmes, North America accounted for the greatest revenue share of more than 40.1% in 2021. Gene editing and synthesis-related processes are increasingly being used by medication and diagnostic companies in the United States, facilitating regional market growth. Furthermore, governmental approval and commercialization of synthetic gene products in the region have aided market expansion. The recent approval of a large number of cellular and gene therapies in the region also encourages additional companies to invest in this area.

Key Players:

Some of the players are Atum, ATDBio Ltd., Bioneer Corporation, Eurofins Scientific, Eurogentec, GenScript Biotech Corporation, Genewiz, Integrated DNA Technologies, Inc., OriGene Technologies, Inc., and Thermo Fisher Scientific, Inc.

Gene Synthesis Market is segmented as follows:

Parameter Details
Segments Covered

By End User

  • Academic and Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Organizations

By Method

  • Oligonucleotide Synthesis
  • Gene Assembly

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Merck KGaA
  • Genewiz Inc.
  • Eurofins Genomics
  • Thermo Fisher Scientific
  • GenScript are the major companies operating in Gene Synthesis Market.
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Gene Synthesis Market is tabulated as follows:

Frequently Asked Question
  • The global Gene Synthesis valued at USD 1.75 Billion in 2022 and is expected to reach USD 8.58 Billion in 2030 growing at a CAGR of 17.60%.

  • The prominent players in the market are Merck KGaA, Genewiz Inc., Eurofins Genomics, Thermo Fisher Scientific, GenScript are the major companies operating in Gene Synthesis Market..

  • The market is project to grow at a CAGR of 17.60% between 2023 and 2030.

  • The driving factors of the Gene Synthesis include

    • Supportive Government Policies

  • North America was the leading regional segment of the Gene Synthesis in 2022.